KTTA
Price
$0.79
Change
-$0.04 (-4.82%)
Updated
Jun 13 closing price
Capitalization
5.85M
SPRO
Price
$2.83
Change
-$0.06 (-2.08%)
Updated
Jun 13 closing price
Capitalization
158.23M
53 days until earnings call
Interact to see
Advertisement

KTTA vs SPRO

Header iconKTTA vs SPRO Comparison
Open Charts KTTA vs SPROBanner chart's image
Pasithea Therapeutics
Price$0.79
Change-$0.04 (-4.82%)
Volume$291.7K
Capitalization5.85M
Spero Therapeutics
Price$2.83
Change-$0.06 (-2.08%)
Volume$2.08M
Capitalization158.23M
KTTA vs SPRO Comparison Chart
Loading...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KTTA vs. SPRO commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KTTA is a Hold and SPRO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (KTTA: $0.79 vs. SPRO: $2.83)
Brand notoriety: KTTA and SPRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KTTA: 3% vs. SPRO: 39%
Market capitalization -- KTTA: $5.85M vs. SPRO: $158.23M
KTTA [@Biotechnology] is valued at $5.85M. SPRO’s [@Biotechnology] market capitalization is $158.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KTTA’s FA Score shows that 1 FA rating(s) are green whileSPRO’s FA Score has 1 green FA rating(s).

  • KTTA’s FA Score: 1 green, 4 red.
  • SPRO’s FA Score: 1 green, 4 red.
According to our system of comparison, SPRO is a better buy in the long-term than KTTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KTTA’s TA Score shows that 4 TA indicator(s) are bullish while SPRO’s TA Score has 7 bullish TA indicator(s).

  • KTTA’s TA Score: 4 bullish, 4 bearish.
  • SPRO’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, SPRO is a better buy in the short-term than KTTA.

Price Growth

KTTA (@Biotechnology) experienced а -11.27% price change this week, while SPRO (@Biotechnology) price change was +13.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

SPRO is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRO($158M) has a higher market cap than KTTA($5.85M). SPRO YTD gains are higher at: 174.757 vs. KTTA (-75.048). KTTA has higher annual earnings (EBITDA): -13.24M vs. SPRO (-73.06M). SPRO has more cash in the bank: 48.9M vs. KTTA (5.34M). KTTA has less debt than SPRO: KTTA (0) vs SPRO (3.96M). SPRO has higher revenues than KTTA: SPRO (28.3M) vs KTTA (0).
KTTASPROKTTA / SPRO
Capitalization5.85M158M4%
EBITDA-13.24M-73.06M18%
Gain YTD-75.048174.757-43%
P/E RatioN/A10.75-
Revenue028.3M-
Total Cash5.34M48.9M11%
Total Debt03.96M-
FUNDAMENTALS RATINGS
SPRO: Fundamental Ratings
SPRO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KTTASPRO
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
71%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
77%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OVBC31.65-0.10
-0.31%
Ohio Valley Banc Corp
ATAT32.30-0.15
-0.46%
Atour Lifestyle Holdings Limited
UHAL62.34-0.96
-1.52%
U-Haul Holding Company
SES0.96-0.04
-3.79%
SES AI Corp
VERB7.10-0.66
-8.51%
Verb Technology Company Inc

KTTA and

Correlation & Price change

A.I.dvisor tells us that KTTA and INCY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and INCY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
-5.21%
INCY - KTTA
28%
Poorly correlated
-2.12%
GNFT - KTTA
22%
Poorly correlated
+1.74%
TRAW - KTTA
22%
Poorly correlated
-6.11%
BPMC - KTTA
21%
Poorly correlated
-0.19%
SPRO - KTTA
21%
Poorly correlated
-2.08%
More

SPRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRO has been loosely correlated with ASBP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRO jumps, then ASBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRO
1D Price
Change %
SPRO100%
-2.08%
ASBP - SPRO
62%
Loosely correlated
-3.82%
CLGN - SPRO
43%
Loosely correlated
-15.48%
ITOS - SPRO
35%
Loosely correlated
+1.90%
XENE - SPRO
32%
Poorly correlated
-0.12%
SYRE - SPRO
31%
Poorly correlated
-2.37%
More